Actively Recruiting
Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2025-07-10
120
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Infections in the lower respiratory tract (lungs) are the leading cause of death from infectious disease worldwide. This was true even before the COVID-19 pandemic. Respiratory viruses are still a major health threat. Many of these viruses infect people by penetrating the thin skin that lines the nose. These viruses can also spread easily to other people when they multiply in the tissues that line the nose. Researchers want to learn more about what these viruses do inside the nose, how they get from the nose to the lungs, and how they spread from person to person. Objective: To collect cell samples from inside the noses of healthy people. These cells will be stored for use in future research on respiratory diseases. Eligibility: Healthy volunteers aged 18 years and older. Design: Most participants will have 1 visit on 1 day. They will be asked questions. Those who have a runny nose, coughing, congestion, or fever will be asked to wait up to 21 days before participating. Participants will be given a slender swab with small bristles at the end. They will rub the inside of their nose with the swab. A clinic staff member will be present to help, if needed. Participants will provide their name, age, and sex. This information will be encoded so that only certain researchers will know the participants identities. Participants will not be contacted again....
CONDITIONS
Official Title
Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Able to provide informed consent
- Willing to allow biological samples and data to be stored for future research
You will not qualify if you...
- History of respiratory symptoms such as runny nose, coughing, congestion, or fever within the past 14 days
- NIH and laboratory staff directly involved in the biobank's operation or maintenance
- Any condition that the investigator judges may put you at undue risk or make you unsuitable for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rocky Mountain Laboratories
Hamilton, Montana, United States, 59840
Actively Recruiting
Research Team
E
Emmie de Wit, Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here